Cytotoxic T-lymphocyte-associated antigen-4 polymorphisms and susceptibility to cervical cancer: A meta-analysis

Molecular Medicine Reports

Volumn 8, Issue 6, 2013, Pages 1785-1794

  Qiu, Hao ^a   Tang, Weifeng ^b   Yin, Pengfei ^a   Cheng, Feng ^a   Wang, Lixin ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b JIANGSU UNIVERSITY   (China)

Author keywords

Cervical cancer; Cytotoxic T lymphocyte associated antigen 4; Gene polymorphism; Meta analysis

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CTLA4 PROTEIN, HUMAN;

ARTICLE; ASIAN; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CAUCASIAN; CONFIDENCE INTERVAL; CONTROLLED STUDY; ETHNICITY; FEMALE; GENETIC ASSOCIATION; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS (TOPIC); RESTRICTION FRAGMENT LENGTH POLYMORPHISM; UTERINE CERVIX CANCER; ALLELE; BIOLOGICAL MODEL; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; PUBLISHING; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE CERVIX TUMOR;

ALLELES; CASE-CONTROL STUDIES; CTLA-4 ANTIGEN; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MODELS, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 84893788191     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1721     Document Type: Article

References (33)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Stanley M: HPV -immune response to infection and vaccination. Infect Agent Cancer 5: 19, 2010.
3. Moore EE, Wark JD, Hopper JL, Erbas B, Garland SM and CeCaGeEn Study Group: The roles of genetic and environmental factors on risk of cervical cancer: a review of classical twin studies. Twin Res Hum Genet 15: 79-86, 2012.
4. Zoodsma M, Sijmons RH, de Vries EG and Zee AG: Familial cervical cancer: case reports, review and clinical implications. Hered Cancer Clin Pract 2: 99-105, 2004.
5. Wank R and Thomssen C: High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3. Nature 352: 723-725, 1991.
6. Rahimifar S, Erfani N, Sarraf Z and Ghaderi A: ctla-4 gene variations may influence cervical cancer susceptibility. Gynecol Oncol 119: 136-139, 2010.
7. Matsumoto K, Oki A, Satoh T, et al: Interleukin-10 -1082 gene polymorphism and susceptibility to cervical cancer among Japanese women. Jpn J Clin Oncol 40: 1113-1116, 2010.
8. Satinder K, Chander SR, Pushpinder K, Indu G and Veena J: Cyclin D1 (G870A) polymorphism and risk of cervix cancer: a case control study in north Indian population. Mol Cell Biochem 315: 151-157, 2008.
9. Teft WA, Kirchhof MG and Madrenas J: A molecular perspective of CTLA-4 function. Annu Rev Immunol 24: 65-97, 2006.
10. Buonavista N, Balzano C, Pontarotti P, Le Paslier D and Golstein P: Molecular linkage of the human CTLA4 and CD28 Ig-superfamily genes in yeast artificial chromosomes. Genomics 13: 856-861, 1992.
11. Ligers A, Teleshova N, Masterman T, Huang WX and Hillert J: CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun 2: 145-152, 2001.
12. Egen JG, Kuhns MS and Allison JP: CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nat Immunol 3: 611-618, 2002.
13. Leach DR, Krummel MF and Allison JP: Enhancement of antitumor immunity by CTLA-4 blockade. Science 271: 1734-1736, 1996.
14. Hurwitz AA, Foster BA, Kwon ED, et al: Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockade. Cancer Res 60: 2444-2448, 2000.
15. Curran MA and Allison JP: Tumor vaccines expressing flt3 ligand synergize with ctla-4 blockade to reject preimplanted tumors. Cancer Res 69: 7747-7755, 2009.
16. Hou R, Cao B, Chen Z, Li Y, et al: Association of cytotoxic T lymphocyte-associated antigen-4 gene haplotype with the susceptibility to gastric cancer. Mol Biol Rep 37: 515-520, 2010.
17. Sun T, Zhou Y, Yang M, et al: Functional genetic variations in cytotoxic T-lymphocyte antigen 4 and susceptibility to multiple types of cancer. Cancer Res 68: 7025-7034, 2008.
18. Lang C, Chen L and Li S: Cytotoxic T-lymphocyte antigen-4 +49G/A polymorphism and susceptibility to pancreatic cancer. DNA Cell Biol 31: 683-687, 2012.
19. Karabon L, Pawlak-Adamska E, Tomkiewicz A, et al: Variations in suppressor molecule ctla-4 gene are related to susceptibility to multiple myeloma in a polish population. Pathol Oncol Res 18: 219-226, 2012.
20. Karabon L, Pawlak E, Tomkiewicz A, et al: CTLA-4, CD28, and ICOS gene polymorphism associations with non-small-cell lung cancer. Hum Immunol 72: 947-954, 2011.
21. Kamesh L, Heward JM, Williams JM, et al: CT60 and +49 polymorphisms of CTLA 4 are associated with ANCA-positive small vessel vasculitis. Rheumatology (Oxford) 48: 1502-1505, 2009.
22. Heidari A, Noori Daloii MR, Keramatipour M, Rashikinezhad A, Sahmani AA and Amirzargar AA: CTLA-4 gene polymorphisms (?318C/T, +49A/G, +6230A/G) in Iranian patients with multiple sclerosis. Iran J Allergy Asthma Immunol 9: 219-223, 2010.
23. Li H, Zhou YF, Guo HY, Sun T, Zhang WH and Lin DX: Association between CTLA-4 gene polymorphism and susceptibility to cervical cancer. Zhonghua Zhong Liu Za Zhi 33: 681-684, 2011 (In Chinese).
24. Jiang L, Luo RY, Zhang W, Wang LR, Wang F and Cheng YX: Single nucleotide polymorphisms of CTLA4 gene and their association with human cervical cancer. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 28: 313-317, 2011 (In Chinese).
25. Hu L, Liu J, Chen X, et al: CTLA-4 gene polymorphism +49 A/G contributes to genetic susceptibility to two infection-related cancers -hepatocellular carcinoma and cervical cancer. Hum Immunol 71: 888-891, 2010.
26. Ivansson EL, Juko-Pecirep I and Gyllensten UB: Interaction of immunological genes on chromosome 2q33 and IFNG in susceptibility to cervical cancer. Gynecol Oncol 116: 544-548, 2010.
27. Pawlak E, Karabon L, Wlodarska-Polinska I, et al: Influence of CTLA-4/CD28/ICOS gene polymorphisms on the susceptibility to cervical squamous cell carcinoma and stage of differentiation in the Polish population. Hum Immunol 71: 195-200, 2010.
28. Castro FA, Haimila K, Sareneva I, et al: Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population - a candidate gene approach. Int J Cancer 125: 1851-1858, 2009.
29. Su TH, Chang TY, Lee YJ, et al: CTLA-4 gene and susceptibility to human papillomavirus-16-associated cervical squamous cell carcinoma in Taiwanese women. Carcinogenesis 28: 1237-1240, 2007.
30. Vriens D, de Wilt JH, van der Wilt GJ, Netea-Maier RT, Oyen WJ and de Geus-Oei LF: The role of [18F]?2-fluoro-2-deoxy-d-glucose-positron emission tomography in thyroid nodules with indeterminate fine-needle aspiration biopsy: systematic review and meta-analysis of the literature. Cancer 117: 4582-4594, 2011.
31. Pereira TV, Rudnicki M, Pereira AC, Pombo-de-Oliveira MS and Franco RF: 5,10-Methylenetetrahydrofolate reductase polymorphisms and acute lymphoblastic leukemia risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15: 1956-1963, 2006.
32. Sousa H, Santos AM, Pinto D and Medeiros R: Is the p53 codon 72 polymorphism a key biomarker for cervical cancer development? A meta-analysis review within European populations. Int J Mol Med 20: 731-741, 2007.
33. de Freitas AC, Gurgel AP, Chagas BS, Coimbra EC and do Amaral CM: Susceptibility to cervical cancer: an overview. Gynecol Oncol 126: 304-311, 2012.